Prednisone
NDC Package 33261-352-48
Package Information
Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Marketed by Aidarex Pharmaceuticals Llc, this product is identified by NDC 33261-352 and is authorized under FDA application ANDA040256.
Identification & Billing
- RxCUI: 198145 - predniSONE 10 MG Oral Tablet
- RxCUI: 198145 - prednisone 10 MG Oral Tablet
- RxCUI: 312615 - predniSONE 20 MG Oral Tablet
- RxCUI: 312615 - prednisone 20 MG Oral Tablet
- RxCUI: 312617 - predniSONE 5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 33261 - Aidarex Pharmaceuticals Llc
- 33261-352 - Prednisone
- 33261-352-48 - 48 TABLET in 1 BOTTLE, PLASTIC
- 33261-352 - Prednisone
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (33261-352). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 33261-352-48 identifies a specific commercial package of 48 tablet in 1 bottle, plastic of Prednisone, labeled by Aidarex Pharmaceuticals Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 48 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aidarex Pharmaceuticals Llc on July 12, 2002. The current certification is valid through December 31, 2019.
What are the primary indications for this medication?
Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.
How is this Aidarex Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 33261035248. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 48 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
